Oregon Health and Science University (OHSU) and RevMedx Inc. won a USAID/Gates-sponsored seed grant to develop a novel treatment for postpartum hemorrhage based on RevMedx’s XSTAT™ technology. The OHSU/RevMedx proposal was selected from more than 400 submissions in the Saving Lives at Birth Grand Challenge—an international effort to dramatically reduce maternal and neonatal deaths.
Oregon Health and Science University and RevMedx Inc. awarded seed grant by “Saving Lives at Birth” Grand Challenge